Phase 3 trial data reveal Covaxin 77.8 pc effective against Covid19: Report
Jun 22, 2021, at 09:50 pm
New Delhi/IBNS: Indigenously made Covid-19 jab, Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against the deadly infection, according to data released from phase 3 trials conducted on 25,800 participants across India, according to media reports.